Vor Biopharma Inc. Common Stock
Symbol: VOR (NASDAQ)
27.80
▼ (-5.54%) -1.629
Company Description:
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Key Stats
- Today's Open: $28.06
- Today's High: $28.06
- Today's Low: $27.801
- Today's Volume: 600
- Yesterday Close: $29.43
- Yesterday High: $30.4
- Yesterday Low: $29
- Yesterday Volume: 331.64K
- Last Min Volume: 152
- Last Min High: $28.017
- Last Min Low: $27.801
- Last Min VWAP: $28.017
Company Profile
- Name: Vor Biopharma Inc. Common Stock
- Website: https://www.vorbio.com
- Listed Date: 2021-02-05
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001817229
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $201.71M
- Round Lot: 100
- Outstanding Shares: 6.85M
- Asset Type: CS
RECENT FILINGS FOR VOR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 4 | View |
| 2025-10-20 | SCHEDULE 13D/A | View |
| 2025-10-20 | 144 | View |
| 2025-10-20 | 144 | View |
| 2025-10-17 | SCHEDULE 13D/A | View |
| 2025-10-17 | 4 | View |
| 2025-10-17 | 4 | View |
| 2025-10-17 | 144 | View |
| 2025-10-17 | 144 | View |
| 2025-10-16 | 144 | View |
| 2025-10-16 | 144 | View |
| 2025-10-16 | SCHEDULE 13D/A | View |
| 2025-10-15 | 4 | View |
| 2025-10-15 | 144 | View |
| 2025-10-15 | 144 | View |
| 2025-10-10 | SCHEDULE 13D/A | View |
| 2025-10-10 | 4 | View |
| 2025-10-08 | SCHEDULE 13D/A | View |
| 2025-10-08 | 4 | View |
| 2025-10-06 | SCHEDULE 13D/A | View |
Latest News on VOR